The role of HLA genetic variants in COVID ‐19 susceptibility, severity, and mortality: A global review
Journal of Clinical Laboratory Analysis · 2024-01 · 38 (1-2)
DOI: 10.1002/jcla.25005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 22.01.2024. Verfasst von Taraneh Hoseinnezhad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Bushehr University of Medical Sciences, Bushehr, Iran. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bushehr University of Medical Sciences.
Abstract (Originalsprache)
Background
The COVID‐19 pandemic has had a profound global impact, with variations in susceptibility, severity, and mortality rates across different regions. While many factors can contribute to the spread and impact of the disease, specifically human leukocyte antigen (HLA) genetic variants have emerged as potential contributors to COVID‐19 outcomes.
Methods
In this comprehensive narrative review, we conducted a thorough literature search to identify relevant studies investigating the association between HLA genetic variants and COVID‐19 outcomes. Additionally, we analyzed allelic frequency data from diverse populations to assess differences in COVID‐19 incidence and severity.
Results
Our review provides insights into the immunological mechanisms involving HLA‐mediated responses to COVID‐19 and highlights potential research directions and therapeutic interventions. We found evidence suggesting that certain HLA alleles, such as HLA‐A02, may confer a lower risk of COVID‐19, while others, like HLA‐C04, may increase the risk of severe symptoms and mortality. Furthermore, our analysis of allele frequency distributions revealed significant variations among different populations.
Conclusion
Considering host genetic variations, particularly HLA genetic variants, is crucial for understanding COVID‐19 susceptibility and severity. These findings have implications for personalized treatment and interventions based on an individual's genetic profile. However, further research is needed to unravel the precise mechanisms underlying the observed associations and explore the potential for targeted therapies or preventive measures based on HLA genetic variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student Research Committee, Bushehr University of Medical Sciences, Bushehr, Iran.
- Department of Hematology, School of Para-Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
- Department of Basic Medical Sciences, Khoy University of Medical Sciences, Khoy, Iran.
ORCID-Profile: Nasrin Soltani, Emad Behboudi
Förderung
- Bushehr University of Medical Sciences
Zitieren
APA
Hoseinnezhad, T., Soltani, N., Ziarati, S., Behboudi, E., & Mousavi, M. J. (2024). The role of HLA genetic variants in COVID ‐19 susceptibility, severity, and mortality: A global review. Journal of Clinical Laboratory Analysis, 38(1-2). https://doi.org/10.1002/jcla.25005
Vancouver
Hoseinnezhad T, Soltani N, Ziarati S, Behboudi E, Mousavi MJ. The role of HLA genetic variants in COVID ‐19 susceptibility, severity, and mortality: A global review. Journal of Clinical Laboratory Analysis. 2024;38(1-2). doi:10.1002/jcla.25005
BibTeX
@article{Hoseinnezhad2024,
author = {Hoseinnezhad, Taraneh and Soltani, Nasrin and Ziarati, Sarina and Behboudi, Emad and Mousavi, Mohammad Javad},
title = {The role of HLA genetic variants in COVID ‐19 susceptibility, severity, and mortality: A global review},
journal = {Journal of Clinical Laboratory Analysis},
year = {2024},
volume = {38},
number = {1-2},
doi = {10.1002/jcla.25005}
}
EUVIMED